The Journey to Generic Oncology
As more oncology therapies transition from innovative medicines to widely available generic treatments, analytical laboratories play a critical role in ensuring these medicines remain safe, effective and accessible to patients. This webinar highlights a range of oncology applications, including olaparib, sorafenib, imatinib, ibrutinib, and the combination of palbociclib and letrozole, demonstrating how modern HPLC methods and alternative column technologies can support assay and impurity analysis while meeting compendial and quality requirements. Attendees will gain practical insights into method modernisation, column selection and analytical strategies that help manufacturers efficiently bring high-quality generic oncology medicines to market.